Metagenomi Inc
MGX2.050USD
-0.090-4.21%
收盘 09/19, 16:00（美东）报价延迟15分钟
76.94M总市值
亏损市盈率 TTM
关于 Metagenomi Inc 公司
Metagenomi, Inc. 是一家精准基因医学公司。该公司专注于利用其全面的宏基因组学衍生工具箱为患者开发治愈性疗法。其多样化和模块化的基因组编辑工具箱旨在精确靶向人类基因组中的任何位点。其全面的基因组编辑工具箱包括可编程核酸酶、碱基编辑器以及 RNA 和 DNA 介导的整合系统，包括主要编辑系统和成簇的规则间隔短回文重复序列 (CRISPR) 相关转座酶 (CAST)。该公司还开发了一个广泛而模块化的基因组编辑系统工具箱，使其能够以位点特异性的方式与人类基因组相互作用，其中每个工具都可以与特定的疾病目标相匹配。其平台使其能够快速有效地找到、筛选和选择具有最高靶向性、特异性和效率的工具，以便将它们开发成基因医学。
公司简介
公司代码MGX
公司名称Metagenomi Inc
上市日期Feb 09, 2024
CEODr. Brian C. Thomas, Ph.D.
员工数量202
证券类型Ordinary Share
年结日Feb 09
公司地址5959 Horton St
城市EMERYVILLE
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94608
电话15108714880
网址https://metagenomi.co/
公司代码MGX
上市日期Feb 09, 2024
CEODr. Brian C. Thomas, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Lead Independent Director
Lead Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.31%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.35%
Bernales (Sebastian Ph.D.)
3.12%
其他
71.37%
持股股东
持股股东
占比
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.31%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.35%
Bernales (Sebastian Ph.D.)
3.12%
其他
71.37%
股东类型
持股股东
占比
Corporation
15.85%
Individual Investor
12.24%
Investment Advisor
8.48%
Hedge Fund
3.20%
Venture Capital
2.96%
Investment Advisor/Hedge Fund
2.37%
Research Firm
1.62%
Sovereign Wealth Fund
0.67%
其他
52.61%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
159
20.26M
54.19%
-7.71M
2025Q1
157
20.44M
54.67%
-7.64M
2024Q4
143
21.51M
57.48%
-2.78M
2024Q3
116
23.74M
63.40%
-1.13M
2024Q2
94
26.05M
69.54%
+4.67M
2024Q1
65
26.68M
71.20%
+16.22M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Bayer HealthCare LLC
4.05M
10.84%
--
--
Sep 30, 2024
Thomas (Brian C)
2.37M
6.33%
-10.79K
-0.45%
Jun 06, 2025
Humboldt Capital, LLC
1.90M
5.07%
--
--
Apr 14, 2025
The Vanguard Group, Inc.
1.46M
3.9%
+188.80K
+14.88%
Mar 31, 2025
Bernales (Sebastian Ph.D.)
1.17M
3.14%
--
--
Apr 14, 2025
Sozo Ventures LLC
581.58K
1.56%
--
--
Mar 31, 2025
Irish (Jian)
579.04K
1.55%
-6.39K
-1.09%
Jun 06, 2025
Catalio Capital Management, LP
528.99K
1.42%
--
--
Mar 31, 2025
Peapod Lane Capital LLC
352.46K
0.94%
+1.24K
+0.35%
Mar 31, 2025
Millennium Management LLC
185.11K
0.5%
+170.70K
+1184.67%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0%
Proshares Ultra Russell 2000
占比0%
ProShares Hedge Replication ETF
占比0%
Global X Russell 2000 ETF
占比0%
Schwab U.S. Small-Cap ETF
占比0%
iShares Russell 2000 ETF
占比0%
ProShares UltraPro Russell2000
占比0%
iShares Russell 2000 Growth ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
